Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRRF | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | RNF149 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
mRNA | CXADR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | RP11-668G10.2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | YAF2 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | DNASE1L3 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
mRNA | ETV5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | C7orf34 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | KCMF1 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | LRP6 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |